Synthego
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation and gene editing to build platforms for science at scale. By vertically integrating hardware, software, bioinformatics, chemistry and molecular biology, Synthego is at the forefront of innovation, advancing the next generation of medicines by providing access to genome editing at an unprecedented scale.
Latest Synthego Content
Webinar
Choosing the Right GMP Partner for Your CRISPR-enabled Cell and Gene Therapy
On-Demand
Speaking at Cell & Gene Therapy 2023, Kevin Holden, PhD from Synthego, presented their talk on synthesizing CRISPR guide RNAs.
Industry Insight
How CRISPR Is Transforming High-Throughput Screening
This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.
Product
Advertisement
High-Quality Clinical-Grade sgRNA
Leverage Synthego's high-quality synthetic sgRNAs in research grade (RG), GMP-like, and GMP grade to support every step of your CRISPR therapy development.
Video
ECLIPSE, An Automated CRISPR Platform for the Large-Scale Generation of Cell Models for the iPSC Neurodegenerative Disease Initiative (iNDI)
Speaking at the Innovations in Disease Modeling online symposium 2022, Kevin holder, PhD, delivers his talk on Synthego's automated CRISPR platform for large-scale generation of cell models.
Article
Cas9 or Cas12? Picking the Right CRISPR System for Your Research
What are the major differences between Cas9 and Cas12, and how can you decide which is right for your research?
Advertisement
